The UMGC provides genomic technologies and services to researchers and clinicians at the University of
Minnesota and to external academic and industry scientists throughout the U.S. and internationally.

  • News

    Testing will remain important even as Minnesotans get vaccinated

    Finding asymptomatic carriers reduces spread. An analysis published last month in JAMA Network Open estimated more than half of all COVID-19 transmission originates in people who don't know they are infected. The UMGC’s highly-automated lab is ideally suited to assist with asymptomatic assurance testing by pooling samples 5:1 to reduce the costs per test.

    February 28, 2021

  • News

    Scientists look to Twin Cities sewers to find COVID variants

    Scientists at the Metropolitan Council and the University of Minnesota's Genomics Center have started work to detect new strains of COVID in the wastewater flowing into the Twin Cities' primary sewage treatment plant in St. Paul.

    February 15, 2021

  • News

    UMGC joins Assurance Testing Alliance

    The Assurance Testing Alliance (ATA) connects laboratories with schools, elder care settings, employers, and other communities that need regular testing. Thus far, ATA member organizations have contracted with several laboratories to enable nationwide impact, including the Broad Institute, Guardant Health, and University of Minnesota's Genomics Center.

    October 6, 2020

  • News

    SARS-CoV-2 strain sequencing service

    The UMGC has developed a PCR amplicon-based SARS-CoV-2 strain sequencing service that leverages protocols developed by the ARTIC Network, while reducing cost and increasing throughput.

    May 18, 2020

  • News

    PacBio Sequel II has arrived

    In our continuing commitment to assess and acquire emerging genomic technologies, we have advanced our long-read sequencing service by installing the PacBio Sequel II. With the Sequel II System, UMN researchers will see longer reads with greater accuracy and generate more HiFi data per SMRT Cell 8M.

    May 11, 2020

  • News

    UMGC helps to launch COVID-19 diagnostic test

    UMGC scientists applied their experience in high-throughput genomics, automation, and LIMS development to develop a scalable, sensitive RT-qPCR assay workflow that amplifies two regions of the inactivated virus.

    March 31, 2020